BioAge Labs, Inc.
BIOA
$10.18
$0.9610.36%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -75.79M | -79.03M | -71.05M | -71.11M | -70.94M |
| Total Depreciation and Amortization | 191.00K | 180.00K | 171.00K | 167.00K | 161.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 11.60M | 10.95M | 9.32M | 8.24M | 13.77M |
| Change in Net Operating Assets | 5.49M | 10.49M | 8.34M | 11.18M | 2.12M |
| Cash from Operations | -58.51M | -57.40M | -53.21M | -51.52M | -54.89M |
| Capital Expenditure | -633.00K | -916.00K | -792.00K | -366.00K | -340.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -80.18M | -93.04M | -77.56M | -- | 0.00 |
| Cash from Investing | -80.81M | -93.96M | -78.35M | -366.00K | -340.00K |
| Total Debt Issued | -- | -- | -- | -- | 0.00 |
| Total Debt Repaid | -6.00M | -6.00M | -6.00M | -6.00M | -5.50M |
| Issuance of Common Stock | 27.65M | 221.83M | 222.25M | 222.25M | 194.61M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 0.00 | 0.00 | 0.00 | 170.00M | 170.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -1.29M | -3.24M | -4.55M | -5.05M | -3.82M |
| Cash from Financing | 20.36M | 212.59M | 211.70M | 381.20M | 355.29M |
| Foreign Exchange rate Adjustments | 69.00K | 21.00K | 50.00K | 81.00K | -121.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -118.90M | 61.25M | 80.18M | 329.39M | 299.94M |